|
|
 |
|
June 27-29, 2017 • MIT, Cambridge, MA |
|
|
|
|
| |
Workshop schedule as of 3.23.17 – sessions, times, and speakers are subject to change.
 |
| |
Time |
Event |
|
| |
8:30 – 9:00 AM |
Continental Breakfast |
|
|
| |
9:00 – 10:00 AM |
NUTS: The Challenge of Technical Life Cycle Management view abstract
Alain Pralong view bio
Chief Executive Officer, Pharma-Consulting ENABLE GmbH
|
|
| |
10:00 – 11:00 AM |
Conjugate Vaccines: Manufacturing and Development Challenges view abstract
Stephen A. Kolodziej view bio
Associate Research Fellow-Group Leader, Pfizer, Inc. |
|
| |
11:00 – 11:30 AM |
Break |
|
| |
11:30 AM – 12:30 PM |
A Well-Characterized Vaccine: A Case Study with GARDASIL® view abstract
Robert Sitrin view bio
Senior Scientist Process Development, PATH
|
|
| |
12:30 – 1:30 PM |
Lunch
|
|
| |
1:30 – 2:30 PM |
Bioprocessing for Vaccine Viruses and Vectors view abstract
John Aunins view bio
Executive Vice President of Bioprocess & Manufacturing and the Chief Technology Officer, Seres Therapeutics, Inc. |
|
| |
2:30 – 3:30 PM |
Quality Control of Human Viral Vaccines: Reducing the Risk of Viral and Microbial Contamination view abstract
Martin Wisher view bio
Head of Regulatory Affairs, BioReliance |
|
| |
3:30 – 4:00 PM |
Break |
|
| |
4:00 – 5:00 PM |
Innovative USP/DSP Approaches Applied to Viral Vaccines view abstract
José Castillo view bio
Co-Founder and Chief Technology Officer, Univercells |
|
| |
5:00 – 6:30 PM |
Influenza Vaccine Development and Manufacture (Case Study: Seasonal Strain Selection and Vaccine Supply Impact) view abstract
Matthew Downham view bio
Associate Director, AstraZeneca |
|
| |
6:30 – 7:30 PM |
Networking Reception |
|
|
|
|
|
 |
|
|
